Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 712603 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
Electronic (PDF)Add to Basket
EnterprisewideAdd to Basket



Genentech, Inc. - SWOT Analysis
Datamonitor, May 2009, Pages: 26


  Description  
  Table of Contents  
    
    
    
   
 Enquire before Buying  
 Send to a Friend  

The Genentech, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Genentech, Inc. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Genentech, a wholly-owned member of the Roche Group, is one of the leading biotechnology companies. The company is engaged in the discovery, development, manufacture and commercialization of medicines to address significant unmet medical needs. The company sells its biotechnology products to wholesalers, specialty distributors or directly to hospital pharmacies and specialist physicians in private practice. The company primarily operates in the US. It is headquartered in South San Francisco, California and employed 11,186 people as of December 2008. The company recorded revenues of $13,418 million during the financial year (FY) ended December 2008, an increase of 14.4% over FY2007. Increase in revenues was majorly due to higher sales of its oncology products. The operating profit of the company was $5,329 million during FY2008, an increase of 26% over FY2007. The net profit was $3,427 million in FY2008, an increase of 23.8% over FY2007.

Scope of the Report

- Provides all the crucial information on Genentech, Inc. required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Genentech, Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Genentech, Inc.
-Data is supplemented with details on Genentech, Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Genentech, Inc.

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available



Customers who bought this item also bought

Analysis of Genentech, Inc.

Partnering Agreements with Genentech 2010

Genentech: PharmaVitae Profile

Genentech, Inc. - Financial and Strategic Analysis Review

Genentech IMS Company Profile

Genentech Inc.: PharmaVitae Profile

Genentech, Inc. - SWOT Framework Analysis

Genentech Partnering Guide 2008

Bemis Company, Inc. - SWOT Analysis

McCormick & Company, Inc. - SWOT Analysis

Avon Products, Inc. - SWOT Analysis

Amgen Inc. - SWOT Analysis



Top of page


   All rights reserved. � Copyright 2010 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds